Thomas David Hull III - Jul 16, 2024 Form 4 Insider Report for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Role
President, CEO, Director
Signature
/s/ Donald T. Gardner III, Attorney-in-fact
Stock symbol
KEQU
Transactions as of
Jul 16, 2024
Transactions value $
-$168,044
Form type
4
Date filed
7/16/2024, 03:05 PM
Previous filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KEQU Common Stock Options Exercise $99.8K +6K +14.16% $16.64* 48.4K Jul 16, 2024 Direct F1
transaction KEQU Common Stock Options Exercise $142K +6K +12.4% $23.62 54.4K Jul 16, 2024 Direct F1
transaction KEQU Common Stock Tax liability -$410K -7.88K -14.49% $52.00 46.5K Jul 16, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KEQU Option to Buy Options Exercise -6K -100% 0 Jul 16, 2024 Common Stock 6K $16.64 Direct F3
transaction KEQU Option to Buy FY17 Options Exercise -6K -100% 0 Jul 16, 2024 Common Stock 6K $23.62 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
F2 Also includes shares withheld by the company to discharge withholding tax obligations of the reporting person.
F3 Employee stock option granted under Employee Stock Option plan under Rule 16b-3.